Sustained effects of grass pollen AIT

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue SUPPL. 95, 2011, Pages 50-52

  Durham, S R ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Disease modifying effect; grass allergy immunotherapy tablet; immunological tolerance; sustained efficacy

Indexed keywords

ANTIHISTAMINIC AGENT; GRASS POLLEN VACCINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; PLACEBO; STEROID;

ALLERGY IMMUNOTHERAPY TABLET; ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; EAR PRURITUS; GRASS POLLEN; GRASS POLLEN ALLERGY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; MOUTH DISEASE; MOUTH EDEMA; MOUTH IRRITATION; ORAL PRURITUS; POLLEN ALLERGY; PRICK TEST; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHINOCONJUNCTIVITIS; SCORING SYSTEM; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; THROAT IRRITATION;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; AGED; ALLERGENS; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; HUMANS; INJECTIONS, SUBCUTANEOUS; MIDDLE AGED; POACEAE; POLLEN; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79958858032     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2011.02639.x     Document Type: Article

References (6)

1. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, et al., Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341: 468-475. (Pubitemid 29372886)
2. Naclerio RM, Proud D, Moylan B, Balcer S, Freidhoff L, Kagey-Sobotka A, et al., A double-blind study of the discontinuation of ragweed immunotherapy. J Allergy Clin Immunol 1997; 100: 293-300.
3. Ott H, Sieber J, Brehler R, Folster-Holst R, Kapp A, Klimek L, et al., Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study. Allergy 2009; 64: 1394-1401.
4. Ott H, Sieber J, Brehler R, Folster-Holst R, Kapp A, Klimek L, et al., Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study. Allergy 2009; 64: 179-186.
5. Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W, et al., Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years. J Allergy Clin Immunol 2008; 121: 512-518.
6. Durham SR, Emminger W, Kapp A, Colombo G, de Monchy JG, Rak S, et al., Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol 2010; 125: 131-138.